Page last updated: 2024-10-23

azathioprine and Carcinoma, Transitional Cell

azathioprine has been researched along with Carcinoma, Transitional Cell in 6 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research Excerpts

ExcerptRelevanceReference
" The correlation between these is poor, in many patients, at the dosage used in man."1.26The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens. ( Hazleman, BL, 1982)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Vuille-Lessard, É1
Montani, M1
Bosch, J1
Semmo, N1
Wang, HB1
Hsieh, HH1
Chen, YT1
Chiang, CY1
Cheng, YT1
Or, R1
Kleinman, Y1
Chajek-Shaul, T1
Hazleman, BL1
Scharf, J1
Nahir, M1
Eidelman, S1
Jacobs, R1
Levin, D1
Biggs, AW1

Other Studies

6 other studies available for azathioprine and Carcinoma, Transitional Cell

ArticleYear
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    Journal of autoimmunity, 2021, Volume: 123

    Topics: 2019-nCoV Vaccine mRNA-1273; Aged; Autoantibodies; Azathioprine; Carcinoma, Transitional Cell; Causa

2021
The outcome of post-transplant transitional cell carcinoma in 10 renal transplant recipients.
    Clinical transplantation, 2002, Volume: 16, Issue:6

    Topics: Adult; Azathioprine; Carcinoma, Transitional Cell; Cyclosporine; Female; Humans; Immunosuppressive A

2002
Azathioprine and urinary bladder tumor.
    Annals of internal medicine, 1983, Volume: 99, Issue:5

    Topics: Adult; Azathioprine; Carcinoma, Transitional Cell; Humans; Lupus Erythematosus, Systemic; Male; Urin

1983
The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens.
    Annals of the rheumatic diseases, 1982, Volume: 41 Suppl 1

    Topics: Adult; Aged; Animals; Arthritis, Rheumatoid; Azathioprine; Carcinoma, Transitional Cell; Chromosome

1982
Carcinoma of the bladder with azathioprine therapy.
    JAMA, 1977, Jan-10, Volume: 237, Issue:2

    Topics: Aged; Azathioprine; Carcinoma, Transitional Cell; Colitis, Ulcerative; Female; Humans; Male; Urinary

1977
Carcinoma of the bladder in a renal transplant patient.
    The Journal of urology, 1973, Volume: 109, Issue:3

    Topics: Azathioprine; Carcinoma, Transitional Cell; Cystoscopy; Kidney Transplantation; Prednisone; Transpla

1973